Urteste S.A. Logo

Urteste S.A.

Develops non-invasive urine tests for the early detection of multiple cancers.

URT | WAR

Overview

Corporate Details

ISIN(s):
PLURTST00010 (+1 more)
LEI:
259400Q4S6JIKFQHGU06
Country:
Poland
Address:
Gdańsk Starodworska 1, 80-137 Gdańsk

Description

Urteste S.A. is a biotechnology company specializing in the development of non-invasive diagnostic technologies for early cancer detection. The company's core focus is on creating a method to detect multiple types of cancer from a single urine sample. This approach aims to identify malignancies at their earliest stages, potentially improving patient survival rates. The development pipeline includes diagnostic tests for various cancers, with projects such as a prototype for detecting brain tumors and planned clinical trials for a pancreatic cancer test.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2023-06-14 16:39
Informacja o treści projektów uchwał zgłoszonych przez Akcjonariusza - Content …
Polish HTML 1.3 KB
2023-06-14 15:40
Zawiadomienie
Polish PDF 272.2 KB
2023-06-14 15:40
Zawiadomienie o zmianie stanu posiadania akcji Spółki. - Content (PL)
Polish HTML 669 bytes
2023-06-12 16:25
Zawiadomienie nr 5
Polish PDF 168.6 KB
2023-06-12 16:25
Zawiadomienie nr 4
Polish PDF 271.4 KB
2023-06-12 16:25
Zawiadomienie nr 3
Polish PDF 183.7 KB
2023-06-12 16:25
Zawiadomienie nr 2
Polish PDF 136.6 KB
2023-06-12 16:25
Zawiadomienie nr 1
Polish PDF 501.9 KB
2023-06-12 16:25
Zawiadomienia o zmianie stanu posiadania akcji Spółki. - Content (PL)
Polish HTML 768 bytes
2023-06-07 15:23
Statut Spółki Urteste S.A.
Polish PDF 158.4 KB
2023-06-07 15:23
Rejestracja podwyższenia kapitału zakładowego i zmian w statucie Spółki - Conte…
Polish HTML 3.1 KB
2023-05-30 17:41
Raport za I kwartał 2023
Polish PDF 1.3 MB
2023-05-26 15:54
Raport niezależnego biegłego rewidenta- dotyczy sprawozdania o wynagrodzeniach …
Polish PDF 286.4 KB
2023-05-26 15:54
Sprawozdanie o wynagrodzeniach Zarządu i RN za 2022 rok
Polish PDF 501.2 KB
2023-05-26 15:54
Wniosek do Rady Nadzorczej o zaopiniowanie SF i pokrycia straty za 2022 rok
Polish PDF 205.0 KB

Automate Your Workflow. Get a real-time feed of all Urteste S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Urteste S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Urteste S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.